Stockreport

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Lunai Bioworks Inc.  (LNAI) 
PDF Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines".LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- [Read more]